Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
First, we leveraged the All of Us Research Program, a large, diverse, dataset with longitudinal electronic health record data, improving the robustness of the findings to real-world clinical populations with diabetes and/or obesity
It has been investigated in research settings for its ability to stimulate endogenous growth hormone release through interaction with ghrelin (GHS-R1a) receptors
Obesity and insulin resistance can also affect other pathways, such as the insulin-like growth factor system
FOXO4-DRI is a senolytic peptide that has shown potential in treating knee joint issues by targeting and removing senescent cells
US$ 21.59
US$ 21.37
US$ 25.01
US$ 20.98
US$ 28.78
